A multidrug-resistant strain of iKlebsiella pneumoniae/i discovered in Brazil highlights a global threat.
Vous n'êtes pas connecté
Scientists have discovered 29 new antibodies that target iKlebsiella pneumoniae,/i a significant contributor to drug-resistant infections. Through
A multidrug-resistant strain of iKlebsiella pneumoniae/i discovered in Brazil highlights a global threat.
In 2022, a strain of iKlebsiella pneumoniae/i isolated from an 86-year-old woman with a urinary infection in Brazil's Northeast region was found to...
Scientists have discovered a way to target elusive circular fragments of DNA that drive the survival of some of the most aggressive cancers, paving...
Want to prevent glioblastoma? By applying new techniques like CRISPR/Cas9 screens, scientists have identified new targets for treating glioblastoma,...
Antibody-drug conjugates (ADCs) have emerged as a promising approach in cancer therapy, offering a ‘magic bullet’ strategy that combines the...
A virulent new strain of antibiotic-resistant bacteria that causes severe disease could be spreading widely across Asia - posing significant...
Researchers have identified an FDA-approved drug that could offer new hope for patients with the rare, fatal genetic disorders Sandhoff and...
Scientists from Yale and other institutions have discovered that tirzepatide, a drug approved to treat type 2 diabetes, may also be highly effective...
A new antibiotic for tuberculosis (TB) targets multidrug-resistant strains, paving the way for advanced treatments and innovative drug development,...
With plans underway for a new “Independent Panel” on Antimicrobial Resistance, endorsed at September’s UN High-Level AMR Meeting, the...